Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
7.48M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
2.09M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$14.8M
-
Value change
-
+$10.4M
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$7.09
Significant Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q2 2024
30 filings reported holding KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share as of Q2 2024.
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.09M shares
of 7.48M outstanding shares and own 27.96% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (891K shares), SR One Capital Management, LP (444K shares), ADAR1 Capital Management, LLC (306K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (148K shares), MILLENNIUM MANAGEMENT LLC (142K shares), VANGUARD GROUP INC (50.3K shares), Virtu Financial LLC (31.1K shares), BlackRock Inc. (21.4K shares), Board of Trustees of The Leland Stanford Junior University (21.1K shares), and GEODE CAPITAL MANAGEMENT, LLC (18.9K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.